Vorsitz: L. Hein (Freiburg im Breisgau), S. Rohrbach (Gießen)
| (V947) | ERKThr188 phosphorylation is a target to specifically prevent pathological cardiac hypertrophy |
| C. Ruppert, M. Vidal, S. Herrmann, F. Weidemann, M. Özkur, A. Gorski, M. Lohse, K. Lorenz (Würzburg) | |
| (V948) | Mice lacking the Endothelin Receptor A only in sympathetic neurons are protected against pressure overload-induced heart failure |
| L. H. Lehmann, M. Kreußer, J. Rostosky, S. Buß, S. Hardt, M. Yanagisawa, H.-J. Gröne, H. A. Katus, J. Backs (Heidelberg; Dallas, US) | |
| (V949) | TRPC1 and TRPC4 are the indispensible members of the TRPC protein family mediating neurohumoral-induced cardiac hypertrophy in mice |
| J. E. Camacho Londoño, Q. Tian, K. Hammer, I. Mathar, J. Camacho Londoño, J.-C. Reil, M. Oberhofer, M. Meissner, S. E. Philipp, F. Schweda, A. Dietrich, L. Kästner, U. Laufs, L. Birnbaumer, V. Flockerzi, M. Freichel (Heidelberg, Homburg/Saar, Regensburg, München; North Carolina, US) | |
| (V950) | Überexpression des AP-1-Inhibitors JDP2 schützt Herzmuskelzellen vor Apoptose und Hypertrophie |
| G. Euler, B. Meyering, C. Hill, A. Würfel, J. Heger, M. Weber, K.-D. Schlüter, R. Schulz (Gießen) | |
| (V951) | Moderate training in a mouse model (Caveolin-1 deficiency) of hypertrophic cardiomyopathy due to eNOS malfunction: Effects on heart function and morphology |
| A. Ebner, N. Steinbronn, J. Mitschke, D. M. Poitz, R. H. Strasser, C. Wunderlich (Dresden) | |
| (V952) | Calcineurin A stabilizes hypoxia-inducible factor- 1 alpha via a heat shock protein(HSP)90 dependent mechanism in myocardial hypertrophy |
| S. Eschricht, K.-U. Jarr, H. A. Katus, N. Frey, E. Chorianopoulos (Heidelberg, Kiel) |